Description
CJC-1295 (No DAC) + Ipamorelin β Growth Hormone Secretagogue Research Peptide
CJC-1295 (No DAC) combined with Ipamorelin is a dual-component research peptide formulation studied for its role in growth hormone signaling pathways. CJC-1295 (No DAC) functions as a growth hormoneβreleasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue (GHRP). Together, they are researched for their synergistic interaction within the endocrine system.
This combination is commonly utilized in laboratory investigations focused on pulsatile growth hormone release, peptide receptor activity, and endocrine response modulation.
Manufactured under strict quality control standards, this formulation provides high purity and consistency for laboratory and research applications.
Key Research Areas:
Growth hormone signaling pathway studies
Endocrine receptor interaction research
Pulsatile hormone release investigations
Peptide synergy and regulatory mechanism analysis
Product Features:
High-purity research grade peptides
Secure, sealed vial packaging
Reliable consistency for research protocols
β οΈ For laboratory and research use only. Not for human consumption or medical use.


